Insmed reported $18.69B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Cytokinetics USD 9.6B 1.95B Aug/2026
DBV Technologies USD 1.23B 327M Mar/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 19.68B 3.43B Aug/2026
Novartis USD 288.26B 25.18B Mar/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
Ultragenyx Pharmaceutical USD 2.12B 1.16B Aug/2026
Vertex Pharmaceuticals USD 137.33B 11.26B Aug/2026